Mogroside IIE,an in vivo metabolite of sweet agent,alleviates acute lung injury via Pla2g2a-EGFR inhibition
Tài liệu tham khảo
X. Gong. The fruits of
Siraitia grosvenorii: a review of a Chinese food-medicine. 2020, 10: 1400.
Y. Chen. Functional study of natural food sweetener mogrosides. 2006, 1: 41-43.
R. Di. Anti-inflammatory activities of mogrosides from
Momordica grosvenori in murine macrophages and a murine ear edema model. 2011, 59(13): 7474-7481.
G.P. Lin. Effect of
Siraitia grosvenorii polysaccharide on glucose and lipid of diabetic rabbits induced by feeding high fat/high sucrose chow. 2007, 2007: 67435.
J. Xiao. Mogroside IIE inhibits digestive enzymes via suppression of interleukin 9/interleukin 9 receptor signalling in acute pancreatitis. 2020, 11: 859.
F. Xu. Exploring
in vitro,
in vivo metabolism of mogroside V and distribution of its metabolites in rats by HPLC-ESI-ITTOF-MS
n. 2015, 115: 418-430.
D.E. Schraufnagel. Air pollution and noncommunicable diseases: a review by the forum of international respiratory societies’ environmental committee, part 2: air pollution and organ systems. 2019, 155(2): 417-426.
J.P. Reilly. Low to moderate air pollutant exposure and acute respiratory distress syndrome after severe trauma. 2019, 199(1): 62-70.
L.B. Ware. The acute respiratory distress syndrome. 2000, 342(18): 1334-1349.
Y. Imai. Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. 2008, 133(2): 235-249.
M. Hernández. Secreted PLA2 induces proliferation in astrocytoma through the EGF receptor: another inflammation-cancer link. 2020, 12: 1014-1023.
A.O. Akinkuolie. Group IIA secretory phospholipase A2, vascular inflammation, and incident cardiovascular disease. 2019, 39(6): 1182-1190.
S.Y. Zhang. Metabolomics analysis reveals that benzo[
a]pyrene, a component of PM
2.5, promotes pulmonary injury by modifying lipid metabolism in a phospholipase A2-dependent manner
in vivo and
in vitro. 2017, 13: 459-469.
A.S. Ali. Exploitation of protein kinase C: a useful target for cancer therapy. 2009, 35(1): 1-8.
S. Papadopoulos. Secretory phospholipase A2-IIA protein and mrna pools in extracellular vesicles of bronchoalveolar lavage fluid from patients with early acute respiratory distress syndrome: a new perception in the dissemination of inflammation. 2020, 13(11): 415.
F.R. D’Alessio. Mouse models of acute lung injury and ARDS. 2018, 1809: 341-350.
L. Tao. Mogroside IIIE attenuates LPS-induced acute lung injury in mice partly through regulation of the TLR4/MAPK/NF-κB axis via AMPK activation. 2017, 31: 1097-1106.
H. Peng. Increased expression of M1 and M2 phenotypic markers in isolated microglia after four-day binge alcohol exposure in male rats. 2017, 62: 29-40.
K. Kowal. CD163 and its role in inflammation. 2011, 49(3): 365-374.
N.T. Mowery. Acute lung injury. 2020, 57(5): 100777.
J.M. Snider. Group IIA secreted phospholipase A2 is associated with the pathobiology leading to COVID-19 mortality. 2021, 131(19): e149236.
E. Dore. Roles of secreted phospholipase A(2) group IIA in inflammation and host defense. 2019, 1864(6): 789-802.
L.H. Boudreau. Platelets release mitochondria serving as substrate for bactericidal group IIA-secreted phospholipase A2 to promote inflammation. 2014, 124(14): 2173-2183.
E. Hurt-Camejo. Phospholipase A(2) in vascular disease. 2001, 89(4): 298-304.
F. Chilton. Would the real role(s) for secretory PLA2s please stand up. 1996, 97(10): 2161-2162.
M. Murakami. Regulatory Functions of Phospholipase A2. 2017, 37(2/3/4/5/6): 127-195.
S.K. Ku. Inhibitory effect of FXa on secretory group IIA phospholipase A2. 2015, 38(3): 987-994.
W.S. Qu. Inhibition of EGFR/MAPK signaling reduces microglial inflammatory response and the associated secondary damage in rats after spinal cord injury. 2012, 9: 178.
H. Tao. Erlotinib protects LPS-induced acute lung injury in mice by inhibiting EGFR/TLR4 signaling pathway. 2019, 51(1): 131-138.
C.Y. Huang. Attenuation of lipopolysaccharide-induced acute lung injury by hispolon in mice, through regulating the TLR4/PI3K/Akt/mTOR and Keap1/Nrf2/HO-1 pathways, and suppressing oxidative stress-mediated ER stress-induced apoptosis and autophagy. 2020, 12(6): 1742.
K.M. Keppler-Noreuil. Somatic overgrowth disorders of the PI3K/AKT/mTOR pathway & therapeutic strategies. 2016, 172: 402-421.
G.J. Huang. Hispolon suppresses SK-Hep1 human hepatoma cell metastasis by inhibiting matrix metalloproteinase-2/9 and urokinase-plasminogen activator through the PI3K/Akt and ERK signaling pathways. 2010, 58: 9468-9475.
J. Tang. EGFR signaling augments TLR4 cell surface expression and function in macrophages via regulation of Rab5a activation. 2020, 11(2): 144-149.
K.Y. Lee. Elevation of CD109 promotes metastasis and drug resistance in lung cancer via activation of EGFR-AKTmTOR signaling. 2020, 111(5): 1652-1662.